DDIT4 and metabolic disease: A growing body of research demonstrates that REDD1 controls critical cellular and metabolic functions [50], and is vital in the pathogenesis of metabolic disorders including diabetic retinopathy [19, 20, 27, 48] and nephropathy [16, 17, 49].